Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,591,437
  • Shares Outstanding, K 49,487
  • Annual Sales, $ 2,621 M
  • Annual Income, $ 252,020 K
  • 60-Month Beta 1.14
  • Price/Sales 3.31
  • Price/Cash Flow 16.11
  • Price/Book 5.24
  • Price/Earnings ttm 24.44
  • Earnings Per Share ttm 7.17
  • Most Recent Earnings 1.84 on 05/07/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 1.27
  • Number of Estimates 9
  • High Estimate 1.40
  • Low Estimate 1.22
  • Prior Year 1.63
  • Growth Rate Est. (year over year) -22.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.57 +29.98%
on 04/24/20
176.60 -1.69%
on 05/18/20
+36.49 (+26.61%)
since 04/22/20
3-Month
95.58 +81.64%
on 03/19/20
176.60 -1.69%
on 05/18/20
-0.03 (-0.02%)
since 02/21/20
52-Week
95.58 +81.64%
on 03/19/20
179.38 -3.22%
on 02/19/20
+44.17 (+34.12%)
since 05/22/19

Most Recent Stories

More News
The Global Pyrogen Testing Market is expected to grow from USD 897.13 Million in 2018 to USD 1,975.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 11.93%

Reportlinker.com announces the release of the report "Global Pyrogen Testing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05871320/?utm_source=GNW...

CRL : 173.61 (-0.92%)
SmarTrend Watching for Potential Pullback in Shares of Charles River La After 2.41% Gain

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $161.88 to a high of $167.89. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of...

CRL : 173.61 (-0.92%)
Charles River Laboratories (CRL) Q1 Earnings and Revenues Surpass Estimates

Charles River (CRL) delivered earnings and revenue surprises of 24.32% and 2.07%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CRL : 173.61 (-0.92%)
Charles River: 1Q Earnings Snapshot

WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Thursday reported first-quarter earnings of $50.8 million.

CRL : 173.61 (-0.92%)
Charles River Laboratories Announces First-Quarter 2020 Results

--- First-Quarter GAAP Earnings per Share of $1.02 and Non-GAAP Earnings per Share of $1.84 -

CRL : 173.61 (-0.92%)
21.9% Return Seen to Date on SmarTrend Charles River La Call (CRL)

SmarTrend identified an Uptrend for Charles River La (NYSE:CRL) on March 25th, 2020 at $115.66. In approximately 1 month, Charles River La has returned 21.94% as of today's recent price of $141.04.

CRL : 173.61 (-0.92%)
Charles River Laboratories (CRL) Reports Next Week: Wall Street Expects Earnings Growth

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRL : 173.61 (-0.92%)
Carl Subsidiary FlowWorks Adds Boulder Colorado to Its Growing List of Clients

Carl Data Solutions (CSE: CRL.CN)(CNSX: CRL) (FRANKFURT: 7C5) (OTC PINK: CDTAF) ("Carl" or the "Company"), a developer of Big-Data-as-a-Service ("BDaaS")-based solutions for data integration, business...

CDTAF : 0.1158 (+3.39%)
CRL.CN : 0.150 (-6.25%)
CRL : 173.61 (-0.92%)
Charles River Laboratories Schedules First-Quarter 2020 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2020 financial results on Thursday, May 7th, before the market opens. A conference call has been scheduled to discuss...

CRL : 173.61 (-0.92%)
Accelerate Diagn is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (AXDX , NSTG , CRL , NEO , LMNX )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

AXDX : 8.43 (+1.93%)
CRL : 173.61 (-0.92%)
NSTG : 31.09 (+3.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CRL with:

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 176.86
1st Resistance Point 175.23
Last Price 173.61
1st Support Level 172.18
2nd Support Level 170.75

See More

52-Week High 179.38
Last Price 173.61
Fibonacci 61.8% 147.37
Fibonacci 50% 137.48
Fibonacci 38.2% 127.59
52-Week Low 95.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar